← Scroll for more →
Champions Oncology, Inc. (CSBR)
Biological Products, (No Diagnostic Substances)
Latest Price
$4.81
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
0.28
P/B Ratio
17.20
Valuation metrics
adjust assumptions →Base FCF: $4M (median of recent 5yr)
Growth: -15%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$1.61
66% downside
Institutional Ownership
42.2% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Battery Management Corp. | 2.42M | $14.0M | 17.40% | -- | 2026-06-30 |
| NEA Management Company, LLC | 1.71M | $10.0M | 12.31% | -- | 2026-06-30 |
| Vanguard Capital Management LLC | 301.4K | $1.0M | 2.17% | +1.8K | 2026-06-30 |
| Tocqueville Asset Management L.P. | 295.7K | $1.0M | 2.12% | -24.0K | 2026-06-30 |
| Morgan Stanley | 235.4K | $1.0M | 1.69% | -6.9K | 2026-06-30 |
| Bank of America Corp | 214.1K | $1.0M | 1.54% | +192.2K | 2026-06-30 |
| Renaissance Technologies LLC | 139.0K | -- | 1.00% | -6.5K | 2026-06-30 |
| BlackRock, Inc. | 129.8K | -- | 0.93% | +5.9K | 2026-06-30 |
| Mink Brook Asset Management LLC | 111.3K | -- | 0.80% | -- | 2026-06-30 |
| Geode Capital Management, LLC | 76.3K | -- | 0.55% | -877 | 2026-06-30 |